Clinical Trials Logo

Stage II clinical trials

View clinical trials related to Stage II.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02938624 Completed - Clinical trials for Non Small Cell Lung Carcinoma

Anti PD-1 Neo-adjuvant Treatment for NSCLC

MK3475-223
Start date: January 7, 2017
Phase: Phase 1
Study type: Interventional

A single arm, phase I, dose escalation trial and expansion cohort, examining the safety and feasibility of neoadjuvant pembrolizumab treatment for early resectable NSCLC patients. Hypothesis: The investigators hypothesize that response rate to neo-adjuvant pembrolizumab will be higher than the response rate of advanced NSCLC patients.